Evidence map›Paper›PMID 41287699›Full record

ReviewCureus2025

Knee Osteoarthritis: Current Insights Into Pathophysiology and Non-surgical Management Options.

Mohammed Elmajee, Mahmoud Mersal, Bibi Zehra, Walid Ben Nafa, Ahmed Elsayed, Osama Embaby, Ahmed Elbioumy, Ahmed Elmahdi, Abdelrahman Embabi, Mohamed Youssef

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohammed ElmajeeSpines, Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, GBR.
Mahmoud MersalTrauma and Orthopaedics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR.
Bibi ZehraSurgery, Good Hope Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR.
Walid Ben NafaTrauma and Orthopaedics, St Helens Hospital, Merseyside, GBR.
Ahmed ElsayedTrauma and Orthopaedics, Manchester Royal Infirmary, Manchester, GBR.
Osama EmbabyOrthopaedics, Mansoura University Hospital, Birmingham, GBR.
Ahmed ElbioumyGenera Surgery, Countess of Chester Hospital NHS Foundation Trust, Chester, GBR.
Ahmed ElmahdiTrauma and Orthopaedics, Salford Royal NHS Foundation Trust, Manchester, GBR.
Abdelrahman EmbabiEmergency Clinical Fellow, Royal Surrey NHS Foundation Trust, Guildford, GBR.
Mohamed YoussefOrthopaedics, Stoke Hospital, Stoke on Trent, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Knee osteoarthritis (OA) is a highly prevalent degenerative joint disorder, characterised by the progressive breakdown of articular cartilage (AC), remodelling of subchondral bone, synovial inflammation, and osteophyte formation. These pathological changes collectively lead to chronic pain, joint stiffness, and functional impairment, significantly diminishing patients' quality of life. This review synthesises contemporary evidence on the pathophysiological mechanisms underpinning knee OA and critically appraises the efficacy of current conservative treatment strategies. Non-pharmacological interventions, such as weight reduction and structured exercise programmes, have consistently demonstrated substantial benefits in alleviating pain and improving functional outcomes. Pharmacological therapies, notably non-steroidal anti-inflammatory drugs (NSAIDs), offer effective symptom relief, while intra-articular interventions, including corticosteroid and hyaluronic acid injections, provide short-term pain control; however, their long-term efficacy remains uncertain. Emerging treatments, such as disease-modifying osteoarthritis drugs (DMOADs), genicular artery embolisation (GAE), and anabolic agents, have shown promising preliminary results, although their precise roles within conservative management require further validation through robust clinical trials. Despite the growing array of therapeutic options, significant challenges persist in optimising conservative management strategies for knee OA. The need for individualised, multimodal approaches that account for patient-specific factors is increasingly recognised. This review highlights the importance of tailored management pathways and emphasises the urgent need for continued research to refine and advance non-surgical interventions for individuals living with knee OA.

Indexed as

cartilage degenerationconservative management of knee deformitydisease-modifying osteoarthritis drugsintra-articular injectionsknee osteoarthritismesenchymal stem cellsplatelet-rich plasmasynovial inflammation

Identifiers

PMID41287699
PMCPMC12640556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.